General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-07-25 | 2024-06 | 1.67 | N/A | N/A | N/A |
2024-04-25 | 2024-03 | -4.55 | -4.4 | 0.15 | 3.30% |
2024-02-02 | 2023-12 | 1.52 | 1.7 | 0.18 | 11.84% |
2023-10-26 | 2023-09 | 1.76 | 2 | 0.24 | 13.64% |
2023-07-27 | 2023-06 | 1.99 | 1.75 | -0.24 | -12.06% |
2023-04-27 | 2023-03 | 1.98 | 2.05 | 0.07 | 3.54% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Underweight | Underweight |
2023-10-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-05 | Truist Securities | Upgrade | Buy | Buy |
2023-09-14 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-14 | TD Cowen | Upgrade | Market Perform | Market Perform |
2023-09-14 | Truist Securities | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-07 | BOERNER CHRISTOPHER S | Chief Executive Officer | 101.21K | Conversion of Exercise of derivative security |
2024-03-07 | CAFORIO GIOVANNI | Officer and Director | 432.27K | Conversion of Exercise of derivative security |
2024-03-07 | ELKINS DAVID VINCENT | Chief Financial Officer | 195.18K | Conversion of Exercise of derivative security |
2024-03-07 | GALLMAN CARI | Officer | 1.43K | Conversion of Exercise of derivative security |
2024-03-07 | HIRAWAT SAMIT | Officer | 60.28K | Conversion of Exercise of derivative security |
2024-03-07 | HOCH LYNELLE BAUMGARDNER | Officer | 1.73K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 203.74M | 13.03B | 9.75% |
2023-06-29 | Blackrock Inc. | 172.67M | 11.04B | 8.27% |
2023-06-29 | JP Morgan Chase & Company | 103.31M | 6.61B | 4.95% |
2023-06-29 | State Street Corporation | 92.57M | 5.92B | 4.43% |
2023-06-29 | Capital International Investors | 69.30M | 4.43B | 3.32% |
2023-06-29 | FMR, LLC | 46.75M | 2.99B | 2.24% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 65.55M | 4.19B | 3.14% |
2023-06-29 | Vanguard 500 Index Fund | 50.02M | 3.20B | 2.39% |
2023-05-30 | Fidelity 500 Index Fund | 23.79M | 1.53B | 1.14% |
2023-08-30 | SPDR S&P 500 ETF Trust | 23.15M | 1.43B | 1.11% |
2023-08-30 | iShares Core S&P 500 ETF | 19.65M | 1.21B | 0.94% |
2023-06-29 | Vanguard Index-Value Index Fund | 18.25M | 1.17B | 0.87% |
Dividend | Date |
---|---|
0.5 | 2024-05-06 |
0.6 | 2024-04-05 |
0.6 | 2024-04-04 |
0.6 | 2024-01-04 |
0.57 | 2023-10-05 |
0.57 | 2023-07-06 |
Split | Date |
---|---|
1000000 : 951777 | 2001-08-07 |
1.05067 : 1 | 2001-08-06 |
2 : 1 | 1999-03-01 |
2 : 1 | 1997-03-03 |
2 : 1 | 1987-06-10 |
2 : 1 | 1983-05-27 |
Sliding into the range of senile joes pole numbers
We’re all in deep do do with this train wreck pharma company and the wreckage is not over. My God the destruction this management failed to prevent.
Not with a 10 foot pole territory
20 some years in pharma stocks have come to halt. Just let them all go. A sad ending but a necessary cut. Adios
So this is finally the turn around? Who says you can’t call the bottom? Scooped it up in the 48/49 level. Let it rip
I’m a buyer when it hits $35 as forecasted.
Everyone states buy,buy,buy while sell,sell,sell. What a bunch of crooks! SEC needs to investigate!
Everyone states buy,buy,buy while sell,sell,sell. What a bunch of crooks!!!
All thanks to Mrs. Karen J Adams that helped me achieve my dreams through her trading program, I made over $30,000 in duration of 4 days she's so excellent and amazing. Visit her on TELEGRAM ᏦᎪᎡᎬΝ Ꭻ ᎪᎠᎪᎷՏ or WhatsApp +❶❽❶❷❷❼⓿❻❽⓿❼
Calling all cars, Calling all cars️️
$BMY finally broke through 78!!
$BMY What in the world is going here??? These folks make a ton of money, pay a dividend, and they own 3 out of the top 5 drugs on the market. They get approvals left and right, and they grind out more and more money every year. Are people out of their minds??? This is a STRONG BUY
They pay a great dividend, they’ve had great trial runs on new drugs, and they make some of the best steadily sold drugs on the market. Just about every amazing analyst I follow owns $BMY. Sometimes the market gets is wrong for a bit. Get ready, she’s about to rocket.
Back to $50’s puts
$BMY...check out $ARCT.. your welcome
Anybody look at Buffets portfolio and unimpressed by all the growth he missed?